152 related articles for article (PubMed ID: 35149084)
1. A simple quinoline salt derivative is active in vitro against Plasmodiumfalciparum asexual blood stages and inhibits the development of cerebral malaria in murine model.
Bezerra Bellei JC; Glanzmann N; Carpinter BA; Renhe DC; Marques CB; Azevedo MR; Barreto LM; Rocha VN; Karine da Costa Nunes I; Gualberto Pereira HM; Coimbra ES; Ferraz Coelho EA; David da Silva A; de Pilla Varotti F; Gorza Scopel KK
Chem Biol Interact; 2022 Mar; 355():109848. PubMed ID: 35149084
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antiplasmodial activity of novel quinoline derivative compounds by molecular hybridization.
Marinho JA; Martins Guimarães DS; Glanzmann N; de Almeida Pimentel G; Karine da Costa Nunes I; Gualberto Pereira HM; Navarro M; de Pilla Varotti F; David da Silva A; Abramo C
Eur J Med Chem; 2021 Apr; 215():113271. PubMed ID: 33596489
[TBL] [Abstract][Full Text] [Related]
3. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
[TBL] [Abstract][Full Text] [Related]
5. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity.
Hochegger P; Faist J; Seebacher W; Saf R; Mäser P; Kaiser M; Weis R
Bioorg Med Chem; 2019 May; 27(10):2052-2065. PubMed ID: 30962114
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives.
Korotchenko V; Sathunuru R; Gerena L; Caridha D; Li Q; Kreishman-Deitrick M; Smith PL; Lin AJ
J Med Chem; 2015 Apr; 58(8):3411-31. PubMed ID: 25654185
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
[TBL] [Abstract][Full Text] [Related]
10. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
[TBL] [Abstract][Full Text] [Related]
11. Orally Effective Aminoalkyl 10H-Indolo[3,2-b]quinoline-11-carboxamide Kills the Malaria Parasite by Inhibiting Host Hemoglobin Uptake.
Mudududdla R; Mohanakrishnan D; Bharate SS; Vishwakarma RA; Sahal D; Bharate SB
ChemMedChem; 2018 Dec; 13(23):2581-2598. PubMed ID: 30358112
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.
Baragaña B; Norcross NR; Wilson C; Porzelle A; Hallyburton I; Grimaldi R; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Wyatt PG; Delves MJ; Meister S; Duffy S; Avery VM; Winzeler EA; Sinden RE; Wittlin S; Frearson JA; Gray DW; Fairlamb AH; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
J Med Chem; 2016 Nov; 59(21):9672-9685. PubMed ID: 27631715
[TBL] [Abstract][Full Text] [Related]
13. The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines.
C S Pinheiro L; M Feitosa L; O Gandi M; F Silveira F; Boechat N
Molecules; 2019 Nov; 24(22):. PubMed ID: 31766184
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
15. Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparum.
Hrycyna CA; Summers RL; Lehane AM; Pires MM; Namanja H; Bohn K; Kuriakose J; Ferdig M; Henrich PP; Fidock DA; Kirk K; Chmielewski J; Martin RE
ACS Chem Biol; 2014 Mar; 9(3):722-30. PubMed ID: 24369685
[TBL] [Abstract][Full Text] [Related]
16. Bisquinoline antimalarials: their role in malaria chemotherapy.
Raynes K
Int J Parasitol; 1999 Mar; 29(3):367-79. PubMed ID: 10333319
[TBL] [Abstract][Full Text] [Related]
17. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.
Camara A; Haddad M; Reybier K; Traoré MS; Baldé MA; Royo J; Baldé AO; Batigne P; Haidara M; Baldé ES; Coste A; Baldé AM; Aubouy A
Malar J; 2019 Dec; 18(1):431. PubMed ID: 31852507
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite.
Stringer T; Quintero MAS; Wiesner L; Smith GS; Nordlander E
J Inorg Biochem; 2019 Feb; 191():164-173. PubMed ID: 30529881
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study.
Kumar R; Sharma R; Kumar I; Upadhyay P; Dhiman AK; Kumar R; Kumar R; Purohit R; Sahal D; Sharma U
Med Chem; 2019; 15(7):790-800. PubMed ID: 30324888
[TBL] [Abstract][Full Text] [Related]
20. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
